Heart Disease in Women: How Pregnancy, Menopause, and Other Factors Affect Risk
Current paradigms about heart attacks were, until recently, primarily based on men. Doctors are now learning how different heart attacks and heart disease can be in men and women. "We know now that when something is not right in a woman, the first line of testing may not reveal the answer," says Yale Medicine cardiologist Erica Spatz, MD.
School of Nursing Lecture Presentation on Feb. 12: "Women, HIV, and Opiate Use Disorder: Bringing Healing to the Center of Care: An Integrated Trauma-informed Behavioral Health Approach"
This lecture, by Rosalind de Lisser, MS, FNP-BC, PMHNP-BC, will be presented at Yale School of Nursing, 400 West Campus Drive, Orange, CT, and made available by Livestream.
Daylong Symposium: "Women Advancing Health and Health Care Equity" on May 29
This informative event will feature prominent women clinicians and scientists who will speak about their work in health and health care equity and share their personal journeys. Sessions on the historical, clinical, advocacy/community engagement, education, and research aspects of health and health care disparities will be followed by a reception.
Ensler to Give Keynote Speech at Women's Mental Health Conference at Yale on Oct. 25
Playwright, activist, performer, and feminist Eve Ensler, best known for her play “The Vagina Monologues,” will be the keynote speaker at the first Women’s Mental Health Conference at Yale to be held Friday, October 25, 2019, at Yale School of Medicine, 333 Cedar St.
Once-Common Hysterectomy Technique Linked to Worse Uterine Cancer Outcomes
Every year, nearly 700,000 American women have surgery to remove their uterus (hysterectomy) or uterine fibroids (myomectomy). A laparoscopic surgical technique once commonly used in these procedures could be worsening the outcomes for women who have undiagnosed uterine cancer at the time of the procedure, Yale Cancer Center scientists report in the Journal of Clinical Oncology.
HEALTH NOTES: Black and Hispanic Cancer Patients Are Underrepresented in Clinical Trials
A new study has shown that clinical trials for new cancer medications rarely analyze data on safety and effectiveness by race and that black and Hispanic patients are consistently underrepresented among participants.
Statement concerning recall of Allergan breast implants following cancer link
At the request of the U.S. Food and Drug Administration, textured breast implants made by Allergan are being recalled. The implants have been linked to a rare cancer called Anaplastic Large Cell Lymphoma. Dr. Tomer Avraham comments.